Abstract
Dystonia is a chronic neurological disorder that hinders the quality of life of affected individuals and causes serious disability. It is often an underdiagnosed or misdiagnosed condition due to the lack of clinical criteria and insufficient amount of research studies on the field. With the main goal of exploring methodological aspects of clinical trials in Dystonia, a review of the literature was conducted through the database engine “Web of Science,” searching for the 100 most cited trials in Dystonia, published between 2005 and 2015. This chapter discusses the findings of this review and provides recommendations for augmenting future research studies in the field.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tarsy D, Simon DK (2006) Dystonia. N Engl J Med 355(8):818–829. https://doi.org/10.1056/NEJMra055549
Defazio G, Abbruzzese G, Livrea P, Berardelli A (2004) Epidemiology of primary dystonia. Lancet Neurol 3(11):673–678. https://doi.org/10.1016/S1474-4422(04)00907-X
Albanese A, Barnes MP, Bhatia KP, Fernandez-Alvarez E, Filippini G, Gasser T, Krauss JK, Newton A, Rektor I, Savoiardo M, Valls-Sole J (2006) A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force. Eur J Neurol 13(5):433–444. https://doi.org/10.1111/j.1468-1331.2006.01537.x
Woods JR, Williams JG, Tavel M (1989) The two-period crossover design in medical research. Ann Intern Med 110(7):560–566
Taylor WJ, Weatherall M (2006) What are open-label extension studies for? J Rheumatol 33(4):642–643
Messerer D, Porzsolt F, Hasford J, Neiss A (1987) Advantages and problems of multicenter therapy studies exemplified by a study of the treatment of metastasizing renal cell carcinoma with recombinant interferon-alpha-2c. Onkologie 10(1):43–49
Krauss JK (2002) Deep brain stimulation for dystonia in adults. Overview and developments. Stereotact Funct Neurosurg 78(3-4):168–182. 68963
Coubes P, Vayssiere N, El Fertit H, Hemm S, Cif L, Kienlen J, Bonafe A, Frerebeau P (2002) Deep brain stimulation for dystonia. Surgical technique. Stereotact Funct Neurosurg 78(3-4):183–191. 68962
Kupsch A, Kuehn A, Klaffke S, Meissner W, Harnack D, Winter C, Haelbig TD, Kivi A, Arnold G, Einhaupl KM, Schneider GH, Trottenberg T (2003) Deep brain stimulation in dystonia. J Neurol 250(Suppl 1):I47–I52. https://doi.org/10.1007/s00415-003-1110-2
Ostrem JL, Starr PA (2008) Treatment of dystonia with deep brain stimulation. Neurotherapeutics 5(2):320–330. https://doi.org/10.1016/j.nurt.2008.01.002
Jankovic J, Hunter C, Dolimbek BZ, Dolimbek GS, Adler CH, Brashear A, Comella CL, Gordon M, Riley DE, Sethi K, Singer C, Stacy M, Tarsy D, Atassi MZ (2006) Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia. Neurology 67(12):2233–2235. https://doi.org/10.1212/01.wnl.0000249308.66959.43
Francisco GE (2004) Botulinum toxin: dosing and dilution. Am J Phys Med Rehabil 83(10 Suppl):S30–S37
Rossetto O, Seveso M, Caccin P, Schiavo G, Montecucco C (2001) Tetanus and botulinum neurotoxins: turning bad guys into good by research. Toxicon 39(1):27–41
Simpson LL (1981) The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol Rev 33(3):155–188
Pagan FL, Harrison A (2012) A guide to dosing in the treatment of cervical dystonia and blepharospasm with Xeomin(R): a new botulinum neurotoxin A. Parkinsonism Relat Disord 18(5):441–445. https://doi.org/10.1016/j.parkreldis.2012.02.008
Brin MF (1997) Botulinum toxin: chemistry, pharmacology, toxicity, and immunology. Muscle Nerve Suppl 6:S146–S168
Comella CL, Jankovic J, Shannon KM, Tsui J, Swenson M, Leurgans S, Fan W, Dystonia Study G (2005) Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia. Neurology 65(9):1423–1429. https://doi.org/10.1212/01.wnl.0000183055.81056.5c
Consky E, Basinki A, Belle L, Ranawaya L, Lang A (1990) The Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS): assessment of validity and inter-rater reliability. Neurology 40(suppl 1):445
Gimeno H, Tustin K, Selway R, Lin JP (2012) Beyond the Burke-Fahn-Marsden dystonia rating scale: deep brain stimulation in childhood secondary dystonia. Eur J Paediatr Neurol 16(5):501–508. https://doi.org/10.1016/j.ejpn.2011.12.014
Guettard E, Roze E, Abada G, Lemesle C, Vidailhet M, Laurent-Vannier A, Chevignard MP (2009) Management of spasticity and dystonia in children with acquired brain injury with rehabilitation and botulinum toxin A. Dev Neurorehabil 12(3):128–138. https://doi.org/10.1080/17518420902927994
Portney LG, Watkins MP (2009) Foundations of clinical research: applications to practice, 3rd edn. Pearson/Prentice Hall, Upper Saddle River, NJ
Stallard N, Whitehead J, Todd S, Whitehead A (2001) Stopping rules for phase II studies. Br J Clin Pharmacol 51(6):523–529
Volkmann J, Mueller J, Deuschl G, Kuhn AA, Krauss JK, Poewe W, Timmermann L, Falk D, Kupsch A, Kivi A, Schneider GH, Schnitzler A, Sudmeyer M, Voges J, Wolters A, Wittstock M, Muller JU, Hering S, Eisner W, Vesper J, Prokop T, Pinsker M, Schrader C, Kloss M, Kiening K, Boetzel K, Mehrkens J, Skogseid IM, Ramm-Pettersen J, Kemmler G, Bhatia KP, Vitek JL, Benecke R, dystonia DBSsgf (2014) Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial. Lancet Neurol 13(9):875–884. https://doi.org/10.1016/S1474-4422(14)70143-7
Chan HY, Chang CJ, Chiang SC, Chen JJ, Chen CH, Sun HJ, Hwu HG, Lai MS (2010) A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism. J Psychopharmacol 24(1):91–98. https://doi.org/10.1177/0269881108096070
Levin J, Singh A, Feddersen B, Mehrkens JH, Botzel K (2014) Onset latency of segmental dystonia after deep brain stimulation cessation: a randomized, double-blind crossover trial. Mov Disord 29(7):944–949. https://doi.org/10.1002/mds.25780
Byl NN, Archer ES, McKenzie A (2009) Focal hand dystonia: effectiveness of a home program of fitness and learning-based sensorimotor and memory training. J Hand Ther 22(2):183–197; quiz 198. https://doi.org/10.1016/j.jht.2008.12.003
McKenzie AL, Goldman S, Barrango C, Shrime M, Wong T, Byl N (2009) Differences in physical characteristics and response to rehabilitation for patients with hand dystonia: musicians’ cramp compared to writers’ cramp. J Hand Ther 22(2):172–181; quiz 182. https://doi.org/10.1016/j.jht.2008.12.006
Rice J, Waugh MC (2009) Pilot study on trihexyphenidyl in the treatment of dystonia in children with cerebral palsy. J Child Neurol 24(2):176–182. https://doi.org/10.1177/0883073808322668
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
De Camargo, C.R.S., Dresser, D., Castillo-Saavedra, L., Fregni, F. (2018). Dystonia. In: Fregni, F. (eds) Clinical Trials in Neurology. Neuromethods, vol 138. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7880-9_6
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7880-9_6
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7879-3
Online ISBN: 978-1-4939-7880-9
eBook Packages: Springer Protocols